Visit us at booth B4
11th European Stroke
Organisation Conference
21-23 May 2025, Helsinki, Finland
Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Join Moleac at ESOC 2025 in Helsinki: Advancing Stroke Care Together
We are thrilled to announce our participation at the European Stroke Organisation Conference (ESOC) from 21ˢᵗ to 23ʳᵈ May 2025 in Helsinki, Finland.
Strengthening Neurological Care: Insights from Moleac’s Scientific Conference in Bali
Last weekend, Moleac hosted a Scientific Conference in Bali in collaboration with our Indonesian partner, Ferron PT Pharmaceuticals.
Advancing Neurological Care: Highlights from Moleac’s Scientific Conference in Montenegro
Celebrating Earth Day: Moleac Supports Seacology’s Conservation Efforts in Malaysia
This week is Earth Day! Moleac is proud to support Seacology (www.seacology.org) in their efforts to protect our planet and empower communities.
Post-Stroke Dementia in Southeast Asia: New Review Highlights Urgent Research and Care Gaps
Expanding Horizons in Alzheimer’s Care: Highlights from Our AD/PD 2025 Symposium
Bringing Hope to Young Fighters: Moleac Partners with Kythe Foundation
Moleac at AD/PD 2025: Advancing Alzheimer’s Disease Management
Our team is at the AD/PD International Conference in Vienna!
New Study Reveals Long-Term Healthcare Impact of Pediatric TBI
Meet Moleac at AD/PD 2025: Advancing Alzheimer’s Care in Vienna
Moleac will be attending the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) from April 1ˢᵗ to 5ᵗʰ, 2025, in Vienna.
